Longitudinal Study of Neurodegenerative Disorders



Status:Recruiting
Conditions:Osteoporosis, Other Indications, Other Indications, Other Indications, Neurology, Neurology, Neurology, Neurology, Orthopedic, Hematology, Metabolic, Metabolic
Therapuetic Areas:Hematology, Neurology, Pharmacology / Toxicology, Rheumatology, Orthopedics / Podiatry, Other
Healthy:No
Age Range:Any
Updated:12/7/2018
Start Date:January 11, 2012
End Date:January 2035
Contact:Jodi Martin
Email:sausjl@upmc.edu
Phone:412-692-6351

Use our guide to learn which trials are right for you!

The purpose of this study is to understand the course of rare genetic disorders that affect
the brain. This data is being analyzed to gain a better understanding of the progression of
the rare neurodegenerative disorders and the effects of interventions.

Patients would be evaluated by a multidisciplinary team at specific time points every 3
months the first year, every 6 months the second year and once a year thereafter.

Inclusion Criteria:

- Any patient with a genetic neurodegenerative disorder

Exclusion Criteria:
We found this trial at
1
site
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
Principal Investigator: Maria L Escolar, MD,MS
Phone: 412-692-6351
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials